← Evidence map

ArticleAging2021

CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer.

Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34717291